A novel PEGylated form of granulocyte colony-stimulating factor, mecapegfilgrastim, for peripheral blood stem cell mobilization in patients with hematologic malignancies

A novel PEGylated form of granulocyte colony-stimulating factor, mecapegfilgrastim, for peripheral blood stem cell mobilization in patients with hematologic malignancies

Abstract Background The Pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) has longer half-life and is given once only, which is more comfortable for patients. We aimed to evaluate the efficacy of mecapegfilgrastim for hematopoietic stem cell (HSC) mobilization in patien...

Full description

Bibliographic Details
Main Authors: Jingjing Wen, Qiaolin Zhou, Lin Shi, Fang Xu, Yiping Liu, Jing Su, Ya Zhang, Wen Qu, Jing Yue
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Cancer
Subjects:
Pegylated granulocyte-colony stimulating factor
Mecapegfilgrastim
Hematologic malignancies
Hematopoietic stem cell mobilization
Lymphocyte count
Predictive factors
Online Access:https://doi.org/10.1186/s12885-023-11197-3

Internet

https://doi.org/10.1186/s12885-023-11197-3

Similar Items